Delivery Order SPE2DB20D9226-SPE2DB26FD1BC
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,547.40 by the Defense Logistics Agency (DLA) on September 12, 2025, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order, with an ultimate completion date of October 3, 2025, is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA under the SPE2DB program, valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $78,961 delivery order by the Defense Logistics Agency on October 21, 2025, for XOLAIR 150 mg/ml syringes. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The ultimate completion date is November 12, 2025, with performance taking place at the vendor's...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,642.20 by the Defense Logistics Agency (DLA) on September 4, 2025. The delivery order is for Xolair 150 mg/ml syringes, with an ultimate completion date of September 25, 2025. This award carries no set-aside designation, allowing the vendor to compete on equal footing in the federal procurement marketplace. The place of...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency on September 17, 2025, for Xolair 150 mg/mL syringes, with a ceiling value of $1,547.40. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, valued at approximately $500 million and valid through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $77,370.00 on September 22, 2025, for the supply of Xolair 150 mg/ml syringes. The contract is a firm fixed-price delivery order with an ultimate completion date of October 14, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the Defense...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $4,642.20 by the Defense Logistics Agency's Medical Supply Chain for the supply of Xolair 150 mg/ml syringes. The award, issued on August 29, 2025, with an ultimate completion date of September 22, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,189.60 by the Defense Logistics Agency on September 2, 2025, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, which carries a potential value of $499,999,999 and remains valid through November...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a firm fixed-price delivery order valued at $5,581.44 by the Defense Logistics Agency (DLA) for the supply of Xolair 300 mg/2 ml syringes. The delivery order, issued on September 10, 2025, carries an ultimate completion date of October 1, 2025, with no set-aside designation applied. This award represents a specific task order issued under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $7,704.99 for Xolair 150 mg/ml by the Defense Logistics Agency's Medical Supply Chain on September 16, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 2, 2025, represents a direct procurement with no set-aside designation applied. The award falls under DMS Pharmaceutical Group's larger single-award...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,547.40 by the Defense Logistics Agency (DLA) for XOLAIR 150 MG/ML Syringe. This firm fixed-price delivery order, issued on September 12, 2025, with an ultimate completion date of October 3, 2025, is being performed at the contractor's location in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS...
- SPE2DB20D9226Indefinite Delivery Contract
- SPE2DB20D9226-SPE2DB26FD1BCDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,189.60 by the Defense Logistics Agency on October 22, 2025, for the supply of Xolair 150 mg/ml syringes. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The underlying IDC, with a ceiling value of $499,999,999 and completion date of December 31, 2036, represents the company's authorization as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. The performance location is Park Ridge, Illinois, and no set-aside designation was used for this award. Xolair is a biologic immunosuppressant agent used primarily for asthma and allergic conditions and aligns with DMS Pharmaceutical Group's established portfolio of specialty pharmaceutical products supplied to Department of Defense medical facilities. The company's demonstrated performance on numerous delivery orders across diverse therapeutic categories positions it as a critical supplier within the federal military pharmaceutical supply chain, with this delivery order supporting recurring medical supply needs of DOD healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 10/22/25 |